Intravitreal Bevacizumab (Avastin) Injection in Ocular Ischemic Syndrome

Purpose To determine whether bevacizumab may improve anatomic and visual outcomes in patients with ocular ischemic syndrome (OIS). Design Interventional case reports. Methods Two patients with OIS presenting with unilateral ocular pain, iris neovascularization, and macular edema. Intravitreal inject...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of ophthalmology 2007-07, Vol.144 (1), p.122-124
Hauptverfasser:	Amselem, Luis, Montero, Javier, Diaz-Llopis, Manuel, Pulido, Jose S, Bakri, Sophie J, Palomares, Paula, Garcia-Delpech, Salvador
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiogenesis Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Bevacizumab Biological and medical sciences Diabetic retinopathy Fluorescein Angiography Humans Injections Intraocular Pressure Iris - blood supply Ischemia - complications Ischemia - drug therapy Macular degeneration Macular Edema - diagnosis Macular Edema - drug therapy Macular Edema - etiology Male Medical imaging Medical sciences Miscellaneous Neovascularization, Pathologic - diagnosis Neovascularization, Pathologic - drug therapy Neovascularization, Pathologic - etiology Ophthalmology Pain Syndrome Tomography, Optical Coherence Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity Vitreous Body
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!